You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Getz Pharma

Showing 1 - 25 of 221
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acne Vulgaris Trial in Rawalpindi (Azithromycin, Probiotic Formula, Benzoyl Peroxide 4 % Topical Cream)

Completed
  • Acne Vulgaris
  • Rawalpindi, Punjab, Pakistan
    PEMH
Nov 30, 2022

Left Ventricular Thrombus Trial in Peshawar (Warfarin, Rivaroxaban 20 MG Oral Tablet, Apixaban 5mg or 2.5mg oral tablet)

Recruiting
  • Left Ventricular Thrombus
  • Peshawar, KPK, Pakistan
    Peshawar Institute of Cardiology
Jul 25, 2023

Premature Coronary Atherosclerosis in Young Adults

Recruiting
  • Atherosclerotic Plaque
  • +3 more
    • Karachi, Sindh, Pakistan
      Tabba Heart Institute
    Dec 13, 2021

    Helicobacter Pylori Infection Trial in Yangon (Clarithromycin 500mg, Amoxicillin 500mg, Tinidazole 500mg)

    Completed
    • Helicobacter Pylori Infection
    • Clarithromycin 500mg
    • +3 more
    • Yangon, Myanmar
      Insein General Hospital
    Oct 16, 2019

    Liver Fat, Liver Fibrosis, Glycemic Control Trial (Ertugliflozin 5 mg, 15mg)

    Not yet recruiting
    • Liver Fat
    • +5 more
    • Ertugliflozin 5 mg, 15mg
    • (no location specified)
    Nov 30, 2022

    Ureteric Stone of Lower Third of Ureter Trial (Tamsulosin Oral Capsule)

    Not yet recruiting
    • Ureteric Stone of Lower Third of Ureter
    • Tamsulosin Oral Capsule
    • (no location specified)
    Aug 3, 2023

    Combination of Ertugliflozin And Sitagliptin Efficacy, Safety &

    Not yet recruiting
    • Efficacy
    • +2 more
    • Combinations of Oral Blood Glucose Lowering Drugs
    • (no location specified)
    Oct 3, 2022

    Quality of Life, Type 2 Diabetes, Metformin+Sitagliptin Trial in Karachi (Metformin / Sitagliptin Oral Tablet)

    Completed
    • Quality of Life
    • +2 more
    • Metformin / Sitagliptin Oral Tablet
    • Karachi, Sindh, Pakistan
      Primary Care Diabetes Association
    Apr 28, 2022

    Type 2 Diabetes Trial in Karachi (Empagliflozin, Vildagliptin)

    Completed
    • Type 2 Diabetes
    • Karachi, Sindh, Pakistan
      Department of Diabetes and Endocrinology at Sindh Government Hos
    Apr 28, 2022

    Type II Diabetes, Efficacy, Self, Safety Issues Trial in Islamabad (Empagliflozin)

    Active, not recruiting
    • Type II Diabetes Mellitus
    • +2 more
    • Islamabad, Pakistan
      Umar Diabetes Foundation
    Dec 20, 2021

    Diabetes, Type 2, NASH - Nonalcoholic Steatohepatitis, NAFLD Trial in Karachi (Pioglitazone, Empagliflozin, Pioglitazone +

    Recruiting
    • Diabetes Mellitus, Type 2
    • +2 more
    • Karachi, Sindh, Pakistan
      Aga Khan University Hospital
    Mar 17, 2022

    Adverse Drug Event, Effect of Drug, Type 2 Diabetes Treated With Insulin Trial in Lahore (Insulin)

    Active, not recruiting
    • Adverse Drug Event
    • +2 more
    • Lahore, Punjab, Pakistan
      Social Security Hospital
    Dec 20, 2021

    Direct Acting Anti-Viral's In Chronic HCV Patients

    Completed
    • Safety Issues
    • Faisalabad, Punjab, Pakistan
      Liver Center Faisalabad
    Dec 10, 2020

    Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

    Completed
    • Healthy
    • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
    • +2 more
    • Cairo, Egypt
      Genuine Research Center GRC
    Mar 2, 2023

    Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)

    Recruiting
    • Bioequivalence
    • RID-TDS 13.3 mg/24 h
    • Exelon® 13.3 mg/24 h
    • Erfurt, Thüringen, Germany
      SocraTec R&D GmbH, Clinical Pharmacology Unit
    May 2, 2023

    Type II Diabetes Trial in Pakistan (Empagliflozin, Usual care group)

    Completed
    • Type II Diabetes Mellitus
    • Quetta, Balochistan, Pakistan
    • +10 more
    Dec 10, 2020

    Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg

    Active, not recruiting
    • Hypertension
    • Coronary Artery Disease
    • Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
    • Norvasc 5 mg tablets of Pfizer Labs
    • Vadodara, Gujarat, India
      Accutest Research Laboratories (I) Pvt. Ltd.
    Apr 10, 2023

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)

    Recruiting
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Olivos, Buenos Aires, Argentina
    • +5 more
    May 10, 2023

    Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))

    Completed
    • Healthy
    • Gleptomet 50/1000(Metformin HCl & Sitagliptin)
    • Janumet 50/1000(Metformin HCl & Sitagliptin)
    • Cairo, Egypt
      Genuine Research Center GRC
    Mar 22, 2023

    Healthy Volunteers Trial in Kistarcsa (BV100, Midazolam)

    Recruiting
    • Healthy Volunteers
    • Kistarcsa, Hungary
      CRU Hungary Kft., Early Phase Unit
    Sep 14, 2022

    Pregnancy Related, Nausea Trial in Moscow (Doxylamine + Pyridoxine)

    Recruiting
    • Pregnancy Related
    • Nausea
    • Doxylamine + Pyridoxine
    • Moscow, Russian Federation
      Llc "Certa Clinic"
    Aug 9, 2022

    Unresectable Angiosarcoma Trial in Tokyo (BNCT)

    Recruiting
    • Unresectable Angiosarcoma
    • BNCT
    • Tokyo, Japan
      National Cancer Center Hospital
    Nov 21, 2022

    Drug Use Trial in Jakarta (Glimepiride, Amaryl®)

    Completed
    • Drug Use
    • Jakarta, DKI Jakarta, Indonesia
      PT Pharma Metric Labs
    Jul 20, 2022

    Knowledge and Practices of ADR Reporting in LMICs

    Completed
    • Adverse Reaction
      • Karachi, Sindh, Pakistan
        Shaheed Zulfiqar Ali Bhutto Medical University
      Mar 5, 2020

      Healthy Trial in Cairo (Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose), Nirmatrelvir 150 mg + Ritonavir 100 mg

      Recruiting
      • Healthy
      • Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose)
      • +2 more
      • Cairo, Egypt
        Genuine Research Center GRC
      Aug 4, 2022